University of Kent-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase †

    Pharmaceutics, Vol. 15, Núm. 1

2022

  1. 5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii

    Acta Tropica, Vol. 232

  2. An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

    ACS infectious diseases, Vol. 8, Núm. 6, pp. 1107-1115

  3. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery

    Acta Tropica, Vol. 236

2021

  1. Heterocyclic Diamines with Leishmanicidal Activity

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3168-3181

  2. In vitro anti-Acanthamoeba activity of flavonoid glycosides isolated from Delphinium gracile, D. staphisagria, Consolida oliveriana and Aconitum napellus

    Parasitology, Vol. 148, Núm. 11, pp. 1392-1400

  3. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  4. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2019

  1. Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB/c mouse model

    Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 5, pp. 865-879